Panic prescribing has become omnipresent during the COVID-19 pandemic.
作者信息
Caplan Arthur L, Upshur Ross
机构信息
Division of Medical Ethics, New York University Grossman School of Medicine, New York, New York, USA.
Department of Family and Community Medicine and.
出版信息
J Clin Invest. 2020 Jun 1;130(6):2752-2753. doi: 10.1172/JCI139562.
Abstract
摘要
相似文献
1
Panic prescribing has become omnipresent during the COVID-19 pandemic.
J Clin Invest. 2020 Jun 1;130(6):2752-2753. doi: 10.1172/JCI139562.
2
Ebola Response Priorities in the Time of Covid-19.
N Engl J Med. 2020 Sep 24;383(13):1202-1204. doi: 10.1056/NEJMp2025512.
3
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
JAMA. 2020 May 19;323(19):1897-1898. doi: 10.1001/jama.2020.4742.
4
Missed Opportunities on Emergency Remdesivir Use.
JAMA. 2020 Jul 28;324(4):331-332. doi: 10.1001/jama.2020.11932.
5
COVID-19 pandemic: what can pharmaceutical formulation and drug delivery experts offer?
Pharm Dev Technol. 2020 Jul;25(6):649. doi: 10.1080/10837450.2020.1764670.
6
COVID-19: Small-Molecule Clinical Trials Landscape.
Curr Top Med Chem. 2020;20(18):1577-1580. doi: 10.2174/156802662018200703154334.
7
COVID-19 amidst Ebola's retreat.
Science. 2020 May 1;368(6490):445. doi: 10.1126/science.abc4859.
8
Cationic drugs and COVID-19.
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420966078. doi: 10.1177/2058738420966078.
9
COVID-19: A Defining Moment for Clinical Pharmacology?
Clin Pharmacol Ther. 2020 Jul;108(1):11-15. doi: 10.1002/cpt.1876.
10
Adapting Ebola training to educate healthcare workers during the SARS-2-CoV pandemic.
Am J Disaster Med. 2020;15(2):137-140. doi: 10.5055/ajdm.2020.0363.
引用本文的文献
1
Ethical challenges of clinical trials with a repurposed drug in outbreaks.
Med Health Care Philos. 2023 Jun;26(2):233-241. doi: 10.1007/s11019-023-10140-4. Epub 2023 Mar 7.
2
Top five ethical lessons of COVID-19 that the world must learn.
Wellcome Open Res. 2021 Jan 29;6:17. doi: 10.12688/wellcomeopenres.16568.1. eCollection 2021.
3
COVID-19 and the generation of novel scientific knowledge: Research questions and study designs.
J Eval Clin Pract. 2021 Jun;27(3):694-707. doi: 10.1111/jep.13550. Epub 2021 Feb 15.
4
COVID-19 and the generation of novel scientific knowledge: Evidence-based decisions and data sharing.
J Eval Clin Pract. 2021 Jun;27(3):708-715. doi: 10.1111/jep.13548. Epub 2021 Feb 13.
5
A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
Infect Dis (Lond). 2020 Sep;52(9):659-661. doi: 10.1080/23744235.2020.1774644. Epub 2020 Jun 4.
本文引用的文献
1
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
N Engl J Med. 2019 Dec 12;381(24):2293-2303. doi: 10.1056/NEJMoa1910993. Epub 2019 Nov 27.
2
Research Ethics Governance in Times of Ebola.
Public Health Ethics. 2017 Apr;10(1):49-61. doi: 10.1093/phe/phw039. Epub 2016 Nov 1.
3
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23.
Zotero 插件